DNA damage response genes and the development of cancer metastasis
- PMID: 24397478
- PMCID: PMC4064942
- DOI: 10.1667/RR13515.1
DNA damage response genes and the development of cancer metastasis
Abstract
DNA damage response genes play vital roles in the maintenance of a healthy genome. Defects in cell cycle checkpoint and DNA repair genes, especially mutation or aberrant downregulation, are associated with a wide spectrum of human disease, including a predisposition to the development of neurodegenerative conditions and cancer. On the other hand, upregulation of DNA damage response and repair genes can also cause cancer, as well as increase resistance of cancer cells to DNA damaging therapy. In recent years, it has become evident that many of the genes involved in DNA damage repair have additional roles in tumorigenesis, most prominently by acting as transcriptional (co-)factors. Although defects in these genes are causally connected to tumor initiation, their role in tumor progression is more controversial and it seems to depend on tumor type. In some tumors like melanoma, cell cycle checkpoint/DNA repair gene upregulation is associated with tumor metastasis, whereas in a number of other cancers the opposite has been observed. Several genes that participate in the DNA damage response, such as RAD9, PARP1, BRCA1, ATM and TP53 have been associated with metastasis by a number of in vitro biochemical and cellular assays, by examining human tumor specimens by immunohistochemistry or by DNA genome-wide gene expression profiling. Many of these genes act as transcriptional effectors to regulate other genes implicated in the pathogenesis of cancer. Furthermore, they are aberrantly expressed in numerous human tumors and are causally related to tumorigenesis. However, whether the DNA damage repair function of these genes is required to promote metastasis or another activity is responsible (e.g., transcription control) has not been determined. Importantly, despite some compelling in vitro evidence, investigations are still needed to demonstrate the role of cell cycle checkpoint and DNA repair genes in regulating metastatic phenotypes in vivo.
Figures
Similar articles
-
High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer -Results from a prospective pilot study using a 37 gene panel.Urol Oncol. 2020 Jul;38(7):637.e17-637.e27. doi: 10.1016/j.urolonc.2020.03.001. Epub 2020 Apr 10. Urol Oncol. 2020. PMID: 32280037
-
DNA repair in cancer initiation, progression, and therapy-a double-edged sword.J Appl Genet. 2019 Nov;60(3-4):329-334. doi: 10.1007/s13353-019-00516-9. Epub 2019 Aug 30. J Appl Genet. 2019. PMID: 31468363 Free PMC article. Review.
-
An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update.Cell Cycle. 2021 Sep;20(18):1760-1784. doi: 10.1080/15384101.2021.1966584. Epub 2021 Aug 26. Cell Cycle. 2021. PMID: 34437813 Free PMC article. Review.
-
Yeast checkpoint controls and relevance to cancer.Cancer Surv. 1997;29:109-32. Cancer Surv. 1997. PMID: 9338099 Review.
-
Transcriptional landscape of DNA repair genes underpins a pan-cancer prognostic signature associated with cell cycle dysregulation and tumor hypoxia.DNA Repair (Amst). 2019 Jun;78:142-153. doi: 10.1016/j.dnarep.2019.04.008. Epub 2019 Apr 24. DNA Repair (Amst). 2019. PMID: 31054516
Cited by
-
Targeting cell cycle regulation via the G2-M checkpoint for synthetic lethality in melanoma.Cell Cycle. 2021 Jun;20(11):1041-1051. doi: 10.1080/15384101.2021.1922806. Epub 2021 May 9. Cell Cycle. 2021. PMID: 33966611 Free PMC article. Review.
-
Nuclear IGF1R interact with PCNA to preserve DNA replication after DNA-damage in a variety of human cancers.PLoS One. 2020 Jul 23;15(7):e0236291. doi: 10.1371/journal.pone.0236291. eCollection 2020. PLoS One. 2020. PMID: 32701997 Free PMC article.
-
The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer.Front Oncol. 2020 Jul 28;10:1256. doi: 10.3389/fonc.2020.01256. eCollection 2020. Front Oncol. 2020. PMID: 32850380 Free PMC article. Review.
-
RAD9A promotes metastatic phenotypes through transcriptional regulation of anterior gradient 2 (AGR2).Carcinogenesis. 2019 Mar 12;40(1):164-172. doi: 10.1093/carcin/bgy131. Carcinogenesis. 2019. PMID: 30295739 Free PMC article.
-
Ataxia telangiectasia mutated: The potential negative regulator in platelet-derived growth factor-BB promoted proliferation of pulmonary arterial smooth muscle cells.Front Cardiovasc Med. 2022 Aug 3;9:942251. doi: 10.3389/fcvm.2022.942251. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35990964 Free PMC article.
References
-
- Curtin NJ. DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer. 2012;12:801–817. - PubMed
-
- de Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis. 2000;21:453–460. - PubMed
-
- Rustgi AK. The genetics of hereditary colon cancer. Genes Dev. 2007;21:2525–2538. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous